New research in colorectal cancers directed by investigators at the Johns Hopkins Kimmel Cancer Center suggests that expression of transcription factors — proteins that help turn specific genes on or off by binding to nearby DNA — may play a central role in the degree of DNA methylation across the genome, contributing to the development of different subtypes of these cancers.
Hologic’s radiographic markers targeted in FDA safety communication
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration
February 28, 2024